Research and Markets (http://www.researchandmarkets.com/research/nn5b3l/thromboembolism) has announced the addition of the "Thromboembolism Global Clinical Trials Review, H2, 2013" report to their offering.

Thromboembolism Global Clinical Trials Review, H2, 2013 provides data on the Thromboembolism clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thromboembolism.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Top Companies Participating in Thromboembolism Therapeutics Clinical Trials

  • Bayer AG
  • Sanofi
  • C. H. Boehringer Sohn AG & Co. KG
  • GlaxoSmithKline plc
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • Daiichi Sankyo Company, Limited
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • The LEO Foundation

Clinical Trial Overview of Top Institutes / Government

  • National Heart, Lung, and Blood Institute
  • Ottawa Hospital Research Institute
  • Hamilton Health Sciences
  • Beijing Chao Yang Hospital
  • University of Zurich
  • Brigham and Women's Hospital
  • Capital District Health Authority, Canada
  • McMaster University
  • Centre Hospitalier Universitaire de Saint Etienne
  • Universita di Padova

For more information visit http://www.researchandmarkets.com/research/nn5b3l/thromboembolism

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Cardiovascular